P53 modifications were also analysed by immunocytochemistry, and all established GBM cell lines had alterations in this protein, showed by P53 staining in their nuclei (Fig 2D, 2I, 2N, 2S, 2Y and 2AD). Here, TP53 is linked to glioblastoma.